These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 9502772

  • 1. Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome.
    Lomri A, Lemonnier J, Hott M, de Parseval N, Lajeunie E, Munnich A, Renier D, Marie PJ.
    J Clin Invest; 1998 Mar 15; 101(6):1310-7. PubMed ID: 9502772
    [Abstract] [Full Text] [Related]

  • 2. The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation.
    Lemonnier J, Delannoy P, Hott M, Lomri A, Modrowski D, Marie PJ.
    Exp Cell Res; 2000 Apr 10; 256(1):158-67. PubMed ID: 10739663
    [Abstract] [Full Text] [Related]

  • 3. Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis.
    Lemonnier J, Haÿ E, Delannoy P, Lomri A, Modrowski D, Caverzasio J, Marie PJ.
    J Bone Miner Res; 2001 May 10; 16(5):832-45. PubMed ID: 11341328
    [Abstract] [Full Text] [Related]

  • 4. Age-related changes in bone formation, osteoblastic cell proliferation, and differentiation during postnatal osteogenesis in human calvaria.
    de Pollak C, Arnaud E, Renier D, Marie PJ.
    J Cell Biochem; 1997 Jan 10; 64(1):128-39. PubMed ID: 9015761
    [Abstract] [Full Text] [Related]

  • 5. Increased expression of protein kinase Calpha, interleukin-1alpha, and RhoA guanosine 5'-triphosphatase in osteoblasts expressing the Ser252Trp fibroblast growth factor 2 receptor Apert mutation: identification by analysis of complementary DNA microarray.
    Lomri A, Lemonnier J, Delannoy P, Marie PJ.
    J Bone Miner Res; 2001 Apr 10; 16(4):705-12. PubMed ID: 11315998
    [Abstract] [Full Text] [Related]

  • 6. A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis.
    Yin L, Du X, Li C, Xu X, Chen Z, Su N, Zhao L, Qi H, Li F, Xue J, Yang J, Jin M, Deng C, Chen L.
    Bone; 2008 Apr 10; 42(4):631-43. PubMed ID: 18242159
    [Abstract] [Full Text] [Related]

  • 7. Regional differentiation of cranial suture-associated dura mater in vivo and in vitro: implications for suture fusion and patency.
    Greenwald JA, Mehrara BJ, Spector JA, Warren SM, Crisera FE, Fagenholz PJ, Bouletreau PJ, Longaker MT.
    J Bone Miner Res; 2000 Dec 10; 15(12):2413-30. PubMed ID: 11127206
    [Abstract] [Full Text] [Related]

  • 8. Increased EFG- and PDGFalpha-receptor signaling by mutant FGF-receptor 2 contributes to osteoblast dysfunction in Apert craniosynostosis.
    Miraoui H, Ringe J, Häupl T, Marie PJ.
    Hum Mol Genet; 2010 May 01; 19(9):1678-89. PubMed ID: 20124286
    [Abstract] [Full Text] [Related]

  • 9. Apert syndrome mutant FGFR2 and its soluble form reciprocally alter osteogenesis of primary calvarial osteoblasts.
    Suzuki H, Suda N, Shiga M, Kobayashi Y, Nakamura M, Iseki S, Moriyama K.
    J Cell Physiol; 2012 Sep 01; 227(9):3267-77. PubMed ID: 22105374
    [Abstract] [Full Text] [Related]

  • 10. Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis).
    De Pollack C, Renier D, Hott M, Marie PJ.
    J Bone Miner Res; 1996 Mar 01; 11(3):401-7. PubMed ID: 8852951
    [Abstract] [Full Text] [Related]

  • 11. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
    Mansukhani A, Bellosta P, Sahni M, Basilico C.
    J Cell Biol; 2000 Jun 12; 149(6):1297-308. PubMed ID: 10851026
    [Abstract] [Full Text] [Related]

  • 12. Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures.
    Ignelzi MA, Wang W, Young AT.
    J Bone Miner Res; 2003 Apr 12; 18(4):751-9. PubMed ID: 12674336
    [Abstract] [Full Text] [Related]

  • 13. The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific.
    Debiais F, Hott M, Graulet AM, Marie PJ.
    J Bone Miner Res; 1998 Apr 12; 13(4):645-54. PubMed ID: 9556064
    [Abstract] [Full Text] [Related]

  • 14. Negative autoregulation of fibroblast growth factor receptor 2 expression characterizing cranial development in cases of Apert (P253R mutation) and Pfeiffer (C278F mutation) syndromes and suggesting a basis for differences in their cranial phenotypes.
    Britto JA, Moore RL, Evans RD, Hayward RD, Jones BM.
    J Neurosurg; 2001 Oct 12; 95(4):660-73. PubMed ID: 11596961
    [Abstract] [Full Text] [Related]

  • 15. Activating (P253R, C278F) and dominant negative mutations of FGFR2: differential effects on calvarial bone cell proliferation, differentiation, and mineralization.
    Ratisoontorn C, Fan GF, McEntee K, Nah HD.
    Connect Tissue Res; 2003 Oct 12; 44 Suppl 1():292-7. PubMed ID: 12952211
    [Abstract] [Full Text] [Related]

  • 16. Role of the extracellular matrix and growth factors in skull morphogenesis and in the pathogenesis of craniosynostosis.
    Carinci P, Becchetti E, Bodo M.
    Int J Dev Biol; 2000 Oct 12; 44(6):715-23. PubMed ID: 11061436
    [Abstract] [Full Text] [Related]

  • 17. The BMP antagonist noggin regulates cranial suture fusion.
    Warren SM, Brunet LJ, Harland RM, Economides AN, Longaker MT.
    Nature; 2003 Apr 10; 422(6932):625-9. PubMed ID: 12687003
    [Abstract] [Full Text] [Related]

  • 18. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells.
    Andrades JA, Han B, Becerra J, Sorgente N, Hall FL, Nimni ME.
    Exp Cell Res; 1999 Aug 01; 250(2):485-98. PubMed ID: 10413602
    [Abstract] [Full Text] [Related]

  • 19. Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders.
    Fragale A, Tartaglia M, Bernardini S, Di Stasi AM, Di Rocco C, Velardi F, Teti A, Battaglia PA, Migliaccio S.
    Am J Pathol; 1999 May 01; 154(5):1465-77. PubMed ID: 10329600
    [Abstract] [Full Text] [Related]

  • 20. Apert p.Ser252Trp mutation in FGFR2 alters osteogenic potential and gene expression of cranial periosteal cells.
    Fanganiello RD, Sertié AL, Reis EM, Yeh E, Oliveira NA, Bueno DF, Kerkis I, Alonso N, Cavalheiro S, Matsushita H, Freitas R, Verjovski-Almeida S, Passos-Bueno MR.
    Mol Med; 2007 May 01; 13(7-8):422-42. PubMed ID: 17622301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.